Literature DB >> 30847509

[Blood pressure targets in patients with diabetes mellitus : What are optimum values?]

J Dederer1, Y Bewarder2, F Mahfoud2, M Böhm2.   

Abstract

Diabetes mellitus and arterial hypertension are the most prevalent diseases in the aging population. Both are important risk factors for the development of cardiovascular complications and are associated with a high mortality. Both diseases are often first recognized late. The prognosis of patients with diabetes mellitus is favorably influenced by an optimal adjustment of blood sugar and blood pressure, as confirmed in large randomized clinical trials. Patients with diabetes mellitus and a blood pressure >130/80 mm Hg should first receive life style counseling with respect to nutrition and activity. Drug treatment for reduction of blood pressure is recommended for a blood pressure ≥140/90 mm Hg.

Entities:  

Keywords:  Cardiovascular risk; Diabetes mellitus; Drug therapy; Hypertension; Life style intervention

Mesh:

Substances:

Year:  2019        PMID: 30847509     DOI: 10.1007/s00059-019-4796-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  46 in total

1.  Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

Authors:  E J Lewis; L G Hunsicker; W R Clarke; T Berl; M A Pohl; J B Lewis; E Ritz; R C Atkins; R Rohde; I Raz
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

2.  Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial.

Authors:  Hisatomi Arima; John Chalmers; Mark Woodward; Craig Anderson; Anthony Rodgers; Stephen Davis; Stephen Macmahon; Bruce Neal
Journal:  J Hypertens       Date:  2006-06       Impact factor: 4.844

3.  Structural alterations in subcutaneous small arteries of normotensive and hypertensive patients with non-insulin-dependent diabetes mellitus.

Authors:  D Rizzoni; E Porteri; D Guelfi; M L Muiesan; U Valentini; A Cimino; A Girelli; L Rodella; R Bianchi; I Sleiman; E A Rosei
Journal:  Circulation       Date:  2001-03-06       Impact factor: 29.690

4.  Dogma disputed: can aggressively lowering blood pressure in hypertensive patients with coronary artery disease be dangerous?

Authors:  Franz H Messerli; Giuseppe Mancia; C Richard Conti; Ann C Hewkin; Stuart Kupfer; Annette Champion; Rainer Kolloch; Athanase Benetos; Carl J Pepine
Journal:  Ann Intern Med       Date:  2006-06-20       Impact factor: 25.391

5.  Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

Authors:  B M Brenner; M E Cooper; D de Zeeuw; W F Keane; W E Mitch; H H Parving; G Remuzzi; S M Snapinn; Z Zhang; S Shahinfar
Journal:  N Engl J Med       Date:  2001-09-20       Impact factor: 91.245

6.  Usefulness of home blood pressure measurement in the morning in type 2 diabetic patients.

Authors:  Kyuzi Kamoi; Masashi Miyakoshi; Satoshi Soda; Susumu Kaneko; Osamu Nakagawa
Journal:  Diabetes Care       Date:  2002-12       Impact factor: 19.112

7.  Masked nocturnal hypertension--a novel marker of risk in type 2 diabetes.

Authors:  M Wijkman; T Länne; J Engvall; T Lindström; C J Ostgren; F H Nystrom
Journal:  Diabetologia       Date:  2009-04-25       Impact factor: 10.122

8.  Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study.

Authors:  Peter Sleight; Josep Redon; Paolo Verdecchia; Giuseppe Mancia; Peggy Gao; Robert Fagard; Helmut Schumacher; Michael Weber; Michael Böhm; Bryan Williams; Janice Pogue; Teo Koon; Salim Yusuf
Journal:  J Hypertens       Date:  2009-07       Impact factor: 4.844

9.  Upward shift of the lower range of coronary flow autoregulation in hypertensive patients with hypertrophy of the left ventricle.

Authors:  A Polese; N De Cesare; P Montorsi; F Fabbiocchi; M Guazzi; A Loaldi; M D Guazzi
Journal:  Circulation       Date:  1991-03       Impact factor: 29.690

10.  Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.

Authors:  David P Dutka; Michael Pitt; Domenico Pagano; Marco Mongillo; David Gathercole; Robert S Bonser; Paolo G Camici
Journal:  J Am Coll Cardiol       Date:  2006-12-05       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.